Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-001310
Filing Date
2013-01-03
Accepted
2013-01-03 17:14:39
Documents
1
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4977
  Complete submission text file 0001209191-13-001310.txt   6474
Mailing Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036
Business Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036 646-214-0700
ZIOPHARM ONCOLOGY INC (Issuer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Mailing Address BBDO 1285 AVENUE OF THE AMERICAS NEW YORK NY 10019
Business Address
CANNON JAMES ANTHONY (Reporting) CIK: 0001338533 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33038 | Film No.: 13508019